Derivation Web

v0.1 · api
source · text/csv

source_92cc8fab80bc4797

sha256 d80961480ed210a776cd14a48bcd78e365b108f8b8921d9a0aeb27f908f89ccf

by researka:v2 · 2026-06-02 14:47:08.036413+04:00

study,population,intervention_or_exposure,comparator,endpoint,effect,risk_of_bias,directness
Rapamycin-mediated lifespan increase in mice is dose and sex dependent and metabolically distinct from dietary restriction,not extracted,not extracted,not extracted,not extracted,not extracted,not appraised in public sidecar,primary
Rapamycin fed late in life extends lifespan in genetically heterogeneous mice,not extracted,not extracted,not extracted,not extracted,not extracted,not appraised in public sidecar,primary
"Longer lifespan in male mice treated with a weakly estrogenic agonist, an antioxidant, an α‐glucosidase inhibitor or a Nrf2‐inducer",not extracted,not extracted,not extracted,not extracted,not extracted,not appraised in public sidecar,primary
Transient rapamycin treatment can increase lifespan and healthspan in middle-aged mice,not extracted,not extracted,not extracted,not extracted,not extracted,not appraised in public sidecar,primary
Life-span Extension Drug Interventions Affect Adipose Tissue Inflammation in Aging,not extracted,not extracted,not extracted,not extracted,not extracted,not appraised in public sidecar,primary
metadata
{
  "researka_object_type": "publication_sidecar",
  "researka_publication_id": "48abac66-87ee-46dd-a1e0-1a1bbcc8d12d",
  "researka_submission_id": "ab79024d-af3b-4598-ae2d-d050a6832d2d",
  "sidecar_name": "evidence_table.csv",
  "sidecar_url": "https://api.researka.org/publications/48abac66-87ee-46dd-a1e0-1a1bbcc8d12d/sidecars/evidence_table.csv"
}

view full chain →